Positron, Disease Management to develop heart disease management tool

Positron Corporation and Disease Management have announced an agreement to co-develop a coronary artery disease prevention and reversal software program and total disease management solution.??

The product will include a heart disease pre-test risk calculator; a Coronary Disease Reversal and Prevention practice management program; a web-based, patient-centric, disease-reversal and life-style modification program; an interpreting and referring physician portal as well as a cost-efficacy and patient-outcomes tracker, according to the Houston-based Positron.??

“The development of our heart disease management solution will help us reach beyond our current molecular imaging targeted business to offer a product to payors, self insured corporations, multi-specialty groups, cardiology groups, hospitals and finally direct to the consumer,” said Joseph G. Oliverio, president of Positron.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.